Dr Martens Plc Stock Net Income
| DOCMF Stock | USD 0.92 0.11 10.68% |
As of the 29th of January, Dr Martens owns the Market Risk Adjusted Performance of (1.16), standard deviation of 2.66, and Information Ratio of (0.18). Dr Martens plc technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Dr Martens plc coefficient of variation and the relationship between the information ratio and kurtosis to decide if Dr Martens plc is priced favorably, providing market reflects its prevailing price of 0.92 per share. Given that Dr Martens plc is a hitting penny stock territory we advise to closely look at its jensen alpha.
Dr Martens' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Dr Martens' valuation are provided below:Dr Martens plc does not right now have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. DOCMF |
Dr Martens 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dr Martens' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dr Martens.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Dr Martens on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Dr Martens plc or generate 0.0% return on investment in Dr Martens over 90 days. Dr Martens is related to or competes with Playtech PLC, Tonies SE, Magazine Luiza, Playtech Plc, and Dream International. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, th... More
Dr Martens Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dr Martens' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dr Martens plc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 19.19 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 1.96 |
Dr Martens Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Martens' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dr Martens' standard deviation. In reality, there are many statistical measures that can use Dr Martens historical prices to predict the future Dr Martens' volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | (1.17) |
Dr Martens January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.10) | |||
| Market Risk Adjusted Performance | (1.16) | |||
| Mean Deviation | 1.45 | |||
| Coefficient Of Variation | (680.75) | |||
| Standard Deviation | 2.66 | |||
| Variance | 7.09 | |||
| Information Ratio | (0.18) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | (1.17) | |||
| Maximum Drawdown | 19.19 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 1.96 | |||
| Skewness | (1.54) | |||
| Kurtosis | 8.24 |
Dr Martens plc Backtested Returns
Dr Martens plc retains Efficiency (Sharpe Ratio) of -0.15, which denotes the company had a -0.15 % return per unit of price deviation over the last 3 months. Dr Martens exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dr Martens' Information Ratio of (0.18), market risk adjusted performance of (1.16), and Standard Deviation of 2.66 to check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 0.34, which means possible diversification benefits within a given portfolio. As returns on the market increase, Dr Martens' returns are expected to increase less than the market. However, during the bear market, the loss of holding Dr Martens is expected to be smaller as well. At this point, Dr Martens plc has a negative expected return of -0.4%. Please make sure to confirm Dr Martens' treynor ratio, day typical price, and the relationship between the information ratio and kurtosis , to decide if Dr Martens plc performance from the past will be repeated in the future.
Auto-correlation | 0.25 |
Poor predictability
Dr Martens plc has poor predictability. Overlapping area represents the amount of predictability between Dr Martens time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dr Martens plc price movement. The serial correlation of 0.25 indicates that over 25.0% of current Dr Martens price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.25 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Dr Martens plc reported net income of 181.2 M. This is 64.52% lower than that of the Consumer Cyclical sector and 82.78% lower than that of the Footwear & Accessories industry. The net income for all United States stocks is 68.27% higher than that of the company.
DOCMF Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dr Martens' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Dr Martens could also be used in its relative valuation, which is a method of valuing Dr Martens by comparing valuation metrics of similar companies.Dr Martens is currently under evaluation in net income category among its peers.
DOCMF Fundamentals
| Return On Equity | 0.64 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 2.75 B | |||
| Shares Outstanding | 1 B | |||
| Shares Owned By Insiders | 3.85 % | |||
| Shares Owned By Institutions | 69.40 % | |||
| Price To Earning | 33.56 X | |||
| Price To Book | 5.71 X | |||
| Price To Sales | 2.43 X | |||
| Revenue | 908.3 M | |||
| Gross Profit | 578.8 M | |||
| EBITDA | 265 M | |||
| Net Income | 181.2 M | |||
| Cash And Equivalents | 228 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 280.9 M | |||
| Debt To Equity | 1.20 % | |||
| Current Ratio | 2.86 X | |||
| Book Value Per Share | 0.35 X | |||
| Cash Flow From Operations | 184.4 M | |||
| Earnings Per Share | 0.21 X | |||
| Price To Earnings To Growth | 0.01 X | |||
| Number Of Employees | 2.23 K | |||
| Beta | 0.0551 | |||
| Market Capitalization | 1.93 B | |||
| Total Asset | 859.1 M | |||
| Z Score | 4.6 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 859.1 M | |||
| Last Dividend Paid | 0.058 |
About Dr Martens Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dr Martens plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Martens using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Martens plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in DOCMF Pink Sheet
Dr Martens financial ratios help investors to determine whether DOCMF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOCMF with respect to the benefits of owning Dr Martens security.